Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Weeks is an Instructor in Medicine at Harvard Medical School and a physician-scientist in the adult leukemia program at Dana-Farber Cancer institute. Dr. Weeks received her MD and PhD from Case Western Reserve University School of Medicine. She completed residency in Internal Medicine at Brigham and Women's Hospital and fellowship in Hematology/Oncology at Dana-Farber/Mass General Brigham Cancer Care Program. Dr. Week's clinic focuses on the care of patients with precursors of the myeloid malignancies including clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). Her research focuses on understanding features of CHIP and CCUS that impact the progression to overt myeloid diseases such as myelodysplastic syndrome (MDS) and acute leukemia.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions